ST-Elevation Myocardial Infarction Clinical Trial
Official title:
IntraCoronary Treatment With Integrilin To Improve ANgiographic Outcomes (IC TITAN - TIMI 47) Trial
The main purpose of this research study is to try to improve the results of the standard treatment for heart attacks. Normally, heart attack patients get a fast dose and a slow dose of eptifibatide in the emergency room, shortly after arriving. This drug is usually given through a vein in the arm. However, eptifibatide can also be injected directly into the heart's blood supply just before angioplasty, a common procedure to unblock a blood vessel in the heart. This new way of giving the drug is being studying.
The primary objective of the IC-TITAN study is to demonstrate that an IC bolus of eptifibatide added to an upstream double-bolus and infusion regimen of eptifibatide administered intravenously and initiated early in the ER will result in significant additional clot resolution in vivo when compared with an IC injection of placebo (saline). The primary endpoint chosen to evaluate this hypothesis is the improvement in percent diameter stenosis of the culprit artery following the IC bolus administration of eptifibatide vs. IC placebo (saline) as assessed with quantitative coronary angiography (QCA). ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01864343 -
Target Temperature Management In Myocardial Infarction - A Pilot Study
|
N/A | |
| Completed |
NCT00962416 -
Comparison of Biomatrix Versus Gazelle in ST-Elevation Myocardial Infarction (STEMI)
|
Phase 4 | |
| Active, not recruiting |
NCT00927615 -
Comparison of Intracoronary Versus Intravenous Abciximab in ST-segment Elevation Myocardial Infarction (CICERO)
|
N/A | |
| Completed |
NCT03135275 -
MULTivessel Immediate Versus STAged RevaScularization in Acute Myocardial Infarction -The MULTISTARS AMI Trial
|
N/A | |
| Recruiting |
NCT02592694 -
Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty
|
Phase 4 | |
| Withdrawn |
NCT01991366 -
Should Integrilin be an Integral Part of Adjunctive Therapy in Patients Undergoing Primary PCI for ST-Elevation MI?
|
||
| Completed |
NCT02158468 -
Effect of Conditioning on Myocardial Damage in STEMI
|
N/A | |
| Completed |
NCT01197729 -
OPTAMI (Optimized Therapy of Acute Myocardial Infarction) - Registry
|
N/A | |
| Completed |
NCT06426537 -
Colchicine's Efficacy in MI Patients: Comparing PCI and Non-Reperfusion Approaches
|
Early Phase 1 | |
| Completed |
NCT01882179 -
Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size
|
Phase 3 | |
| Completed |
NCT00952224 -
Myocardial Salvage Assessed by Cardiovascular Magnetic Resonance - Impact on Outcome
|
N/A | |
| Completed |
NCT00378391 -
European Registry on STEMI Patients Transferred for PCI With Upstream Use of Abciximab - EuroTransfer Registry
|
N/A | |
| Withdrawn |
NCT04303377 -
Early Treatment With Evolocumab in Patients With ST-elevation Myocardial Infarction
|
Phase 2 | |
| Completed |
NCT03523624 -
Factor XIII and Other Biomarkers in ST Segment Elevation Myocardial Infarction
|
||
| Completed |
NCT01531114 -
PraSugrel vs TicagrElor in ST-Elevation Myocardial Infarction paTients With Diabetes Mellitus
|
Phase 3 | |
| Active, not recruiting |
NCT01960933 -
Primary PCI in Patients With ST-elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization
|
N/A | |
| Completed |
NCT00502528 -
Endothelin Receptor Blockade in Acute ST-elevation Myocardial Infarction
|
Phase 2 | |
| Recruiting |
NCT02062554 -
Brasilia Heart Study
|
||
| Recruiting |
NCT04150016 -
In-stent Repair and Vessel Reaction of STEMI Patients With OCT
|
N/A | |
| Recruiting |
NCT03074214 -
Prognostic Value of Copeptin for Infarct Size and Prognosis in Patients With ST-elevation Myocardial Infarction
|
N/A |